SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer

BACKGROUND: The clinical outcome of triple-negative breast cancer (TNBC) is poor. Finding more targets for the treatment of TNBC is an urgent need. SENPs are SUMO-specific proteins that play an important role in SUMO modification. Among several tumor types, SENPs have been identified as relevant bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Youzhi, Zhang, Jiasheng, Yu, Liangfei, Xu, Sunwang, Chen, Ling, Wu, Kunlin, Kong, Lingjun, Lin, Wei, Xue, Jiajie, Wang, Qingshui, Lin, Yao, Chen, Xiangjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868814/
https://www.ncbi.nlm.nih.gov/pubmed/36698419
http://dx.doi.org/10.3389/fonc.2022.972969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868814/
https://www.ncbi.nlm.nih.gov/pubmed/36698419
http://dx.doi.org/10.3389/fonc.2022.972969

Ejemplares similares